Drugs and the FDA: Safety, Efficacy, and the Public's Trust - Paperback

Drugs and the FDA: Safety, Efficacy, and the Public's Trust - Paperback

$27.95
Sale price  $27.95 Regular price 
Skip to product information
Drugs and the FDA: Safety, Efficacy, and the Public's Trust - Paperback

Drugs and the FDA: Safety, Efficacy, and the Public's Trust - Paperback

$27.95
Sale price  $27.95 Regular price 

by Mikkael A. Sekeres (Author)

How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin.

Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate US authority on a drug's safety and efficacy? In Drugs and the FDA, Mikkael Sekeres--a leading oncologist and former chair of the FDA's cancer drug advisory committee--tells the story of how the FDA became the most trusted regulatory agency in the world. It took a series of tragedies and health crises, as well as patient advocacy, for the government to take responsibility for ensuring the efficacy and safety of drugs and medical devices.

Before the FDA existed, drug makers could hawk any potion, claim treatment of any ailment, and make any promise on a label. But then, throughout the twentieth century, the government was forced to take action when children were poisoned by contaminated diphtheria and smallpox vaccines, an early antibiotic contained antifreeze, a drug prescribed for morning sickness in pregnancy caused babies to be born disfigured, and access to AIDS drugs was limited to a few clinical trials while thousands died. Sekeres describes all these events against the backdrop of the contentious 2011 hearings on the breast cancer drug Avastin, in which he participated as a panel member. The Avastin hearings, he says, put to the test a century of the FDA's evolution, demonstrating how its system of checks and balances works--or doesn't work.

Author Biography

Mikkael A. Sekeres is Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, and former Chair of the Oncologic Drugs Advisory Committee of the FDA. A regular contributor to the Well section of the New York Times, he is the author of When Blood Breaks Down: Life Lessons from Leukemia (MIT Press).

Number of Pages: 320
Dimensions: 0.87 x 8.66 x 5.59 IN
Publication Date: February 06, 2024

Intentional design

We make things that work better and last longer. Our products solve real problems with clean design.

Quality first

We obsess over the details and strive to deliver the best products at the best prices, every time.

Customer care

We're always on your side: keeping our loyal customers happy is our top priority and number one goal.

At the heart of every product lies a unique story, driven by our passion for quality and innovation. Each item enhances your everyday life and sparks joy.